Story
Resonant Clinical Solutions Acquires Creapharm Bioservices
Resonant Clinical Solutions has acquired Creapharm Bioservices to expand its cryogenic storage and advanced therapy capabilities in Europe. The move bolsters Resonant's ability to support complex clinical programs, particularly in cell and gene therapies, where specialized handling and storage are critical.
Resonant Clinical Solutions is expanding its specialized capabilities through acquisition, enhancing its support for complex therapeutic development programs, particularly in advanced therapies. This strategic move positions the company to capitalize on the increasing trend of advanced modalities in clinical trials.
